Cargando…

A novel alternative splicing-based prediction model for uteri corpus endometrial carcinoma

Alternative splicing (AS) is crucial a mechanism by which the complexity of mammalian and viral proteom increased overwhelmingly. There lacks systematic and comprehensive analysis of the prognostic significance of AS profiling landscape for uteri corpus endometrial carcinoma (UCEC). In this study, u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Li, Xie, Zu-cheng, Pang, Jin-shu, Li, Tian-tian, Chen, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339785/ https://www.ncbi.nlm.nih.gov/pubmed/30640723 http://dx.doi.org/10.18632/aging.101753

Ejemplares similares

Cancer of the corpus uteri: 2021 update
por: Koskas, Martin, et al.
Publicado: (2021)

A Note on the Papillary Adenoma of the Corpus Uteri
por: Liebow, Averill A.
Publicado: (1936)

A chromosome study of seven near-diploid carcinomas of the corpus uteri.
por: Baker, M. C.
Publicado: (1968)

Corpus Uteri Cancer in Kazakhstan: Recent Incidence Trends
por: Zhanerke, Zhanerke, et al.
Publicado: (2023)

A Statistical Report on 955 Cases of Cancer of the Cervix Uteri and 321 Cases of Cancer of the Corpus Uteri
por: Harnett, W. L.
Publicado: (1949)

Incidence and mortality of corpus uteri cancer in China, 2008−2012
por: Xi, Yunfeng, et al.
Publicado: (2019)

Mortality prediction in women with corpus uteri cancer in Brazil: a 21-year analysis
por: Dantas, Diego Bessa, et al.
Publicado: (2020)

Identification of immune-related gene signature for predicting prognosis in uterine corpus endometrial carcinoma
por: Song, Siyuan, et al.
Publicado: (2023)

Liquid Biopsy as a Tool for Differentiation of Leiomyomas and Sarcomas of Corpus Uteri
por: Dvorská, Dana, et al.
Publicado: (2019)

Alternative ANKHD1 transcript promotes proliferation and inhibits migration in uterine corpus endometrial carcinoma
por: Sun, Wenhuizi, et al.
Publicado: (2022)

CXCL9 correlates with antitumor immunity and is predictive of a favorable prognosis in uterine corpus endometrial carcinoma
por: Xue, Shen, et al.
Publicado: (2023)

Trends in Mortality Rates of Corpus Uteri and Ovarian Cancer in Lithuania, 1987–2016
por: Everatt, Rūta, et al.
Publicado: (2020)

Role of alternative splicing signatures in the prognosis of glioblastoma
por: Xie, Zu‐cheng, et al.
Publicado: (2019)

RPP40 is a prognostic biomarker and correlated with tumor microenvironment in uterine corpus endometrial carcinoma
por: Tang, Jianming, et al.
Publicado: (2022)

Adjuvant vaginal interventional radiotherapy in early-stage non-endometrioid carcinoma of corpus uteri: a systematic review
por: De Felice, Francesca, et al.
Publicado: (2021)

Identification of novel key genes associated with uterine corpus endometrial carcinoma progression and prognosis
por: Li, Haixia, et al.
Publicado: (2023)

Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma
por: Zhou, Cankun, et al.
Publicado: (2020)

Metabolism-associated molecular classification of uterine corpus endometrial carcinoma
por: Zhao, Munan, et al.
Publicado: (2023)

Deciphering comprehensive features of tumor microenvironment controlled by chromatin regulators to predict prognosis and guide therapies in uterine corpus endometrial carcinoma
por: Wu, Qihui, et al.
Publicado: (2023)

Myelin and Lymphocyte Protein (MAL): A Novel Biomarker for Uterine Corpus Endometrial Carcinoma
por: Li, Dong, et al.
Publicado: (2021)

Carcinoma Uteri with Pregnancy
por: House, John G.
Publicado: (1854)

Carcinoma Uteri, Treatment
Publicado: (1874)

Novasure as a Mechanical Endometrial Preparation Agent in Large Uteri
por: Potti, Sushma, et al.
Publicado: (2012)

Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Endometrial Cancer
por: Chen, Peigen, et al.
Publicado: (2020)

Alternative splicing of PSMD13 mediated by genetic variants is significantly associated with endometrial cancer risk
por: He, Sisi, et al.
Publicado: (2023)

Carcinosarcoma of the corpus uteri (Malignant Müllerian Mixed Tumor): a case report in Yaoundé (Cameroon)
por: Sando, Zacharie, et al.
Publicado: (2013)

Alternative splicing of synuclein gamma in endometrial cancer: identification of a novel isoform
por: Schaal, Kathrin, et al.
Publicado: (2015)

Comprehensive Analysis of the Expression and Prognosis for MCM4 in Uterine Corpus Endometrial Carcinoma
por: Pei, Li-Peng, et al.
Publicado: (2022)

Coexistence of adenomyosis uteri and endometrial cancer is associated with an improved prognosis compared with endometrial cancer only
por: Hertlein, Linda, et al.
Publicado: (2017)

Construction of a Competitive Endogenous RNA Network in Uterine Corpus Endometrial Carcinoma
por: Ouyang, Dong, et al.
Publicado: (2019)

Prognostic Potential of Alternative Splicing Markers in Endometrial Cancer
por: Wang, Qian, et al.
Publicado: (2019)

Development of an Oxidative Phosphorylation-Related and Immune Microenvironment Prognostic Signature in Uterine Corpus Endometrial Carcinoma
por: Liu, Jinhui, et al.
Publicado: (2021)

Presence of sensory nerve corpuscles in the human corpus and cervix uteri during pregnancy and labor as revealed by immunohistochemistry
por: Tingaker, Berith K, et al.
Publicado: (2006)

LHX1 as a potential biomarker regulates EMT induction and cellular behaviors in uterine corpus endometrial carcinoma
por: Tian, Ye, et al.
Publicado: (2022)

Novel DNA Damage-Related Subtypes Characterization Identifies Uterine Corpus Endometrial Carcinoma (UCEC) Based on Machine Learning
por: Yu, Qi, et al.
Publicado: (2022)

Prognostic significance of mutant-allele tumor heterogeneity in uterine corpus endometrial carcinoma
por: Hou, Yufang, et al.
Publicado: (2020)

Identification of Tumor Microenvironment-Related Alternative Splicing Events to Predict the Prognosis of Endometrial Cancer
por: Liu, Xuan, et al.
Publicado: (2021)

Risk and prognosis of second corpus uteri cancer after radiation therapy for pelvic cancer: A population-based analysis
por: Yu, Guanhua, et al.
Publicado: (2022)

Erratum: Construction of a Competitive Endogenous RNA Network in Uterine Corpus Endometrial Carcinoma
por: Ouyang, Dong, et al.
Publicado: (2021)

Mechanism investigation and experiment validation of capsaicin on uterine corpus endometrial carcinoma
por: Lin, Zhiheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qla5eebqdg3g3j876sap5gv6qk